Search Results 1101-1110 of 11270 for Antifungal Resistance

1. A Study To Assess The Safety And Tolerability Of CFT8634 In Locally Advanced Or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma And SMARCB1-Null Tumors - Mayo Clinic

   Concurrent administration of strong cytochrome P450 (CYP) 3A4 inhibitors and inducers, and multidrug resistance mutation 1 inhibitors. Note: If a subject ...

2. Hodgkin Lymphoma (Hodgkin Disease) Clinical Trials - Mayo Clinic Research

   ... fungal-free survival at Day 90 (±7 days). The primary objective of the European Medicines Agency (EMA) for this study is to demonstrate superiority in ...

3. A Study Of CNTO 136 (Sirukumab), A Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, In Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

   The purpose of this study is to assess the efficacy of sirukumab as measured by the reduction of the signs and symptoms of rheumatoid arthritis (RA) in patients ...

4. Testing The Addition Of A New Drug, Venetoclax, To The Usual Treatment (Ibrutinib And Rituximab) For Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Participants must not have known active bacterial, viral, fungal, mycobacterial, parasitic, or other infection (excluding fungal infections of nail beds) at ...

5. Imatinib (oral route) - Side effects & dosage - Mayo Clinic

   Wear disposable gloves while preparing, giving, withdrawing, or taking this medicine. Remove the child-resistant bottle cap by pushing it down firmly and ...

6. First In Human Study Of KO-539 To Treat Relapsed Or Refractory Acute Myeloid Leukemia - Mayo Clinic

   ... antifungals, and antivirals that are used as standard of care or to prevent ... Patient has an active uncontrolled acute or chronic systemic fungal, bacterial, ...

7. General Internal Medicine - Clinical trials

   This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical ...

8. A Placebo-Controlled Study Of Oral Ozanimod As Maintenance Therapy For Moderately To Severely Active Crohn's Disease - Mayo Clinic

   Subject is receiving treatment with breast cancer resistance protein (BCRP) inhibitors (e.g., cyclosporine, eltrombopag). Subjects is receiving treatment ...

9. A Study To Evaluate The Safety, Pharmacokinetics, And Anti-tumor Activity Of LYT-200 Alone And Combined With Chemotherapy Or Tislelizumab To Treat Patients With Metastatic Solid Tumors - Mayo Clinic

   For Part 1, hormonal androgen deprivation therapy is allowed to continue for patients with metastatic castration-resistant prostate cancer. Any ablative ...

10. Arthritis - Doctors and departments - Mayo Clinic

    Learn about how different types of arthritis affect joints in different ways, along with how to get relief from arthritis pain.